STAPLED HAEMORRHOIDOPEXY IN THE TREATMENT OF HAEMORRHOIDAL PROLAPSE – COMPARISON OF HTA REPORTS, FOR TWO ITALIAN REGIONS
Author(s)
Berto P1, Lopatriello S1, Schivazappa C1, Benvenuti F2, Boccasanta P3, Bordoni L4, Lenisa L5, Naldini G6, Nepi S2, Todaro A7, Valeri A71PBE Consulting, Verona, Italy, 2Ospedale Valdelsa, Poggibonsi, Italy, 3Fondazione IRCCS Ospedale Policlinico Mangiagalli e Regina Elena, Milano, Italy, 4Ospedale di Circolo e Fondazione Macchi, Varese, Italy, 5Casa di Cura S. Pio X, Milano, Italy, 6Ospedale Policlinico Santa Chiara, Pisa, Italy, 7Azienda Ospedaliera Careggi, Firenze, Italy
OBJECTIVES: Surgical management of Haemorrhoidal Disease includes Milligan-Morgan (MM) haemorrhoidectomy and Stapled Haemorrhoidopexy (PPH). Scope of work was to compare HTA Reports for PPH vs. MM (especially cost and budget impact analyses) for two Italian Regions: Lombardia and Toscana. METHODS: Literature search; identification of the surgical course (intervention, hospital admission) and global course (clinical evaluation, surgical phase, follow-up) at the local hospital level; micro-costing for PPH vs. MM at 3 hospitals per Region; comparison of direct medical costs, reimbursement tariffs and budgetary impact in 2008 Euro values. RESULTS: PPH surgical pattern generates costs to Hospitals of €2,306 and €2,177/case, respectively in Lombardia and Toscana; MM surgery costs are €1558 and €1277/case, respectively. Higher unitary costs of personnel and operating theatre in Lombardia drive higher surgical intervention costs, irrespective of procedure type. Whereas hospital admission costs were similar for PPH (€698 vs €638), the gap between Lombardia and Toscana widens for MM hospitalization costs (€812 vs €638), because of longer length of stay in full admission setting. The Lombardia DRG158 tariff (€1209) is not sufficient to recap costs of both alternatives, whilst the Toscana tariff (€1400) is remunerative only for MM, but not when applying higher levels of operating theatre unit cost. The global course generates costs of €2532 (PPH-Lombardia) and €2400 (PPH-Toscana) vs €1781 (MM-Toscana) and €1527 (MM-Toscana). Sensitivity analyses on literature data confirmed the robustness of basecase results. Budget impact analysis, based on regional statistics for haemorrhoidal surgery and suggested extra-tariffs for PPH, estimated the need for additional funding ranging 1.7%-16% for Lombardia and 2.2%-20.4% for Toscana, over the current Regional expenditure. CONCLUSIONS: Analysis of management courses showed the inadequacy of current regional funding for PPH and MM. Current regionalization of the Italian NHS prompts for implementation of HTA at the Regional level.
Conference/Value in Health Info
2009-10, ISPOR Europe 2009, Paris, France
Value in Health, Vol. 12, No. 7 (October 2009)
Code
PGI23
Topic
Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes
Disease
Gastrointestinal Disorders